Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
adjuvant therapy | additional treatment after primary therapy intended to reduce recurrence risk | Adjuvant therapy was discussed following surgical pathology review. | Assessment | Cancer, treatment response and transplant assessment |
administration discrepancy | difference between a written order and the actual administration | The administration discrepancy involved the evening dose recorded on the transfer sheet. | Assessment | Medication response, exposure and reconciliation |
advanced | at a later stage of the disease process | Prior specialist staging documents advanced liver disease. | Assessment | Course, trajectory and response to therapy |
adverse | unwanted or harmful | The timing raises concern for an adverse medication effect. | Assessment | Medication response and safety |
allergy | suspected or established immune-mediated reaction | The immediate hives support a possible drug allergy. | Assessment | Medication response and safety |
allograft biopsy | tissue sample from a transplanted organ | Allograft biopsy provided the histologic basis for the transplant team's assessment. | Assessment | Cancer, treatment response and transplant assessment |
allograft dysfunction | reduced function of a transplanted organ from any of several possible causes | Allograft dysfunction was assessed against the patient's baseline and timing after transplant. | Assessment | Cancer, treatment response and transplant assessment |
antibody-mediated rejection | allograft injury meeting organ-specific criteria for an antibody-mediated process | Antibody-mediated rejection was classified using the transplant service's findings. | Assessment | Cancer, treatment response and transplant assessment |
anticholinergic burden | combined effects of medicines with anticholinergic activity | The review identifies high anticholinergic burden across the home medicines. | Assessment | Medication exposure, response and adverse-effect reasoning |
assay-specific target | target defined using a particular measurement method | The assay-specific target was checked before comparing results reported by two laboratories. | Assessment | Medication response, exposure and reconciliation |
assay variability | variation attributable to measurement methods or performance | The small difference is being reviewed in light of assay variability. | Assessment | Medication exposure, response and adverse-effect reasoning |
augmented renal clearance | renal elimination exceeds that expected in the clinical setting | The augmented renal clearance was considered after review of the measured creatinine clearance. | Assessment | Medication response, exposure and reconciliation |
below-quantitation result | analyte is below the assay's stated range for reliable quantification | The below-quantitation result was preserved with the laboratory's qualifier and units. | Assessment | Medication response, exposure and reconciliation |
bioavailability | fraction of a dose reaching the systemic circulation unchanged | A formulation change may have altered bioavailability. | Assessment | Medication response and safety |
biochemical recurrence | return of a disease-associated marker meeting the relevant recurrence criterion | Biochemical recurrence was assessed using the named marker and disease-specific definition. | Assessment | Cancer, treatment response and transplant assessment |
bioequivalence | similarity of rate and extent of absorption under specified conditions | The dispensing review documents the reference used to verify bioequivalence. | Assessment | Medication exposure, response and adverse-effect reasoning |
biological variability | physiologic variation between measurements | Day-to-day biological variability may contribute to the observed difference. | Assessment | Medication exposure, response and adverse-effect reasoning |
biphasic course | two distinct phases of illness | The fever had a biphasic course with improvement before its return. | Assessment | Course, trajectory and response to therapy |
blinded treatment assignment | the treatment group allocated to a trial participant is concealed from specified people | The coordinator verified the study kit number. Blinded treatment assignment prevented identification of active drug versus placebo during reconciliation. | Assessment | Medication response, exposure and reconciliation |
breakthrough | occurs despite ongoing preventive or maintenance treatment | Breakthrough pain occurs mainly during dressing changes. | Assessment | Medication response and safety |
capacity-limited elimination | elimination is constrained by a process with finite capacity | Capacity-limited elimination was discussed in the pharmacokinetic interpretation. | Assessment | Medication response, exposure and reconciliation |
chelation interaction | drug binds a metal ion and may become less available for absorption | The chelation interaction was considered after the mineral supplement schedule changed. | Assessment | Medication response, exposure and reconciliation |
class effect | effect shared by drugs within a pharmacologic group | Class effect was considered when the symptom recurred with a second drug in the same group. | Assessment | Medication response, exposure and reconciliation |
clearance | efficiency of drug removal from the body | The change in kidney function may affect drug clearance. | Assessment | Medication response and safety |
clinical correlation | interpret laboratory or test data together with symptoms and examination | The isolated laboratory flag requires clinical correlation with the current findings. | Assessment | Medication exposure, response and adverse-effect reasoning |